Actively Recruiting
Long-Term Evaluation of the Rigicon Infla10 Three-Piece Inflatable Penile Prosthesis for Treating Erectile Dysfunction
Led by Rigicon, Inc. · Updated on 2026-08-13
182
Participants Needed
7
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to assess the long-term safety and effectiveness of the Rigicon Infla 10 Three-Piece Inflatable Penile Prosthesis in men with erectile dysfunction ED. ED is a common male sexual dysfunction linked to various health conditions and affects quality of life. The study follows patients implanted with this device for up to three years to evaluate outcomes. Participants will receive the Rigicon Infla 10 inflatable penile prosthesis as a treatment for ED. After implantation, subjects will be followed according to the study protocol and standard care for ED and related health issues. Follow-up visits are scheduled at 14 days, 6 weeks, 6 months, 12 months, 18 months, 24 months, and 36 months post-procedure. During the study, participants will undergo assessments including safety monitoring for device- or procedure-related adverse events, an objective test of penile rigidity at 12 months, and evaluations of erectile function and self-esteem over time. Researchers will also track durability of the device and collect questionnaire responses. The full participation period may extend up to three years after implantation.
CONDITIONS
Brief Title
Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)
Research Team
Z
Zeynep Tin Konukcu
F
Feyzanur CALDIRAN, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here